Diabetes-Focused Senseonics Sets $60M IPO
Venture-backed Senseonics Holdings Inc., which is developing a glucose monitoring device to treat diabetes, set terms Monday on a $60 million initial public offering, marking the second life sciences company in...To view the full article, register now.
Already a subscriber? Click here to view full article